A convenient two-step synthesis of amino acid derived chiral 3-substituted [1,4]benzodiazepin-2-ones

Synthesis

Volumn , Issue 11, 2005, Pages 1881-1887

  Mishra, Jitendra Kumar ^a   Panda, Gautam ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

3 Substituted 1,4 benzodiazepin 2 ones; Amino acids; Chiral; Iron acetic acid; Pyrrolo 2,1 c 1,4 benzodiazepin 2 ones

Indexed keywords

IRON COMPOUNDS; SYNTHESIS (CHEMICAL);

2-NITROBENZYL BROMIDE; DIAZEPINE; RING FORMATION; TWO-STEP SYNTHESIS;

AMINO ACIDS;

(2 OXO 2,3,4,5 TETRAHYDRO 1H BENZO[E][1,4]DIAZEPIN 3 YL)ACETIC ACID METHYL ESTER; 1,2,3,5,10,11A HEXAHYDROBENZO[E]PYRROLO[1,2 A][1,4]DIAZEPIN 11 ONE; 1,5,10,11A TETRAHYDRO 2H BENZO[E]PYRROLO[1,2 A][1,4]DIAZEPIN 3,11 DIONE; 2 HYDROXY 1,2,3,5,10,11A HEXAHYDROBENZO[E]PYRROLO[1,2 A][1,4]DIAZEPIN 11 ONE; 3 (2 METHYLSULFANYLETHYL)1,3,4,5 TETRAHYDROBENZO[E][1,4]DIAZEPIN 2 ONE; 3 (2 OXO 2,3,4,5 TETRAHYDRO 1H BENZO[E][1,4]DIAZEPIN 3 YL)PROPIONAMIDE; 3 (4 BENZYLOXYBENZYL)1,3,4,5 TETRAHYDROBENZO[E][1,4]DIAZEPIN 2 ONE; 3 1H INDOL 3 YLMETHYL)1,3,4,5 TETRAHYDROBENZO[E][1,4]DIAZEPIN 2 ONE; 3 BENZYL 1,3,4,5 TETRAHYDROBENZO[E][1,4]DIAZEPIN 2 ONE; 3 BENZYLSULFANYLMETHYL 1,3,4,5 TETRAHYDROBENZO[E][1,4]DIAZEPIN 2 ONE; 3 ISOBUTYL 1,3,4,5 TETRAHYDROBENZO[E][1,4]DIAZEPIN 2 ONE; AMINO ACID; BENZODIAZEPIN 2 ONE DERIVATIVE; DIAZEPINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; RING CLOSING METATHESIS; SYNTHESIS;

EID: 23044512243     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-869950     Document Type: Article

References (20)

1. CDRI communication number 6708.
2. (a) Hurley, L. H.; Boyd, F. L. Trends Pharmacol. Sci. 1988, 9, 402.
3. (b) Hurley, L. H. J. Med. Chem. 1989, 32, 2027.
4. (c) Thurston, D. E.; Thompson, A. S. Chem. Br. 1990, 26, 767.
5. (a) Albright, J. D.; Reich, M. F.; Delos Santos, E. G.; Dusza, J. P.; Sum, F.-W.; Venkatesan, A. M.; Coupet, J.; Chan, P. S.; Ru, X.; Mazandarani, H.; Bailey, T. J. Med. Chem. 1998, 41, 2442.
6. (b) Shimada, Y.; Taniguchi, N.; Matsuhisa, A.; Sakamato, K.; Yatsu, T.; Tanka, A. Chem. Pharm. Bull. 2000, 48, 1644.
7. Thurston, D. E.; Bose, D. S. Chem. Rev. 1994, 94, 433.
8. (a) Breslin, H. J.; Kukla, M. J.; Kromis, T.; Cullis, H.; de Knaep, F.; Pauwels, R.; Andries, K.; De Clercq, E.; Janssen, M. A. C.; Janssen, P. A. J. Bioorg. Med. Chem. 1999, 7, 2427.
9. (b) Ettmayer, P.; Chloupek, S.; Weignnd, K. J. Comb. Chem. 2003, 5, 253.
10. (c) Sabb, A. L.; Vogel, R. L.; Welmaker, G. S.; Sabalski, J. E.; Coupet, J.; Dunlop, J.; Lipson, S. R.; Harrison, B. Bioorg. Med. Chem. Lett. 2004, 14, 2603.
11. (d) Racker, R.; Doring, K.; Reiser, O. J. Org. Chem. 2000, 65, 6932.
12. (e) Nilov, D.; Racker, R.; Reiser, O. Synthesis 2002, 2232.
13. Selnick, H. G.; Liverton, N. J.; Baldwin, J. J.; Butcher, J. W.; Claremon, D. A.; Elliot, J. M.; Freidinger, R. M.; King, S. A.; Libby, B. E.; McIntyre, C. J.; Pribush, D. A.; Remy, D. C.; Smith, G. R.; Tebben, A. J.; Jurkiewicz, N. K.; Lynch, J. J.; Salata, J. J.; Sanguinetti, M. C.; Siegl, P. K.; Slaughter, D. E.; Vyas, K. J. Med. Chem. 1997, 40, 3865.
14. (a) Davidson, J. R. J. Clin. Psychiatry 2001, 62, 46.
15. (b) McCall, W. V. J. Clin. Psychiatry 2001, 62, 27.
16. (c) Hanley, D. F.; Pozo, M. Int. J. Clin. Pract. 2000, 54, 30.
17. Carabateas, P. M. US Patent 3732212, 1973.
18. (a) Liskamp, M. J. Angew. Chem., Int. Ed. Engl. 1994, 33, 305.
19. (b) De Tullio, P.; Delarge, J.; Pirotte, B. Exp. Opin. Invest. Drugs 2000, 9, 129.
20. Thurston, D. E. Advances in the Study of Pyrrolo[2,1-c][1,4] benzodiazepine (PBD) Antitumour Antibiotics, In Molecular Aspects of Anticancer Drug-DNA Interactions, Vol. 1; Neidle, S.; Waring, M. J., Eds.; Macmillan Press Ltd: London, 1993, 54.